Back

Three-year major clinical outcomes of phosphorylcholine polymer- versus BioLinx polymer-zotarolimus-eluting stents: A propensity score matching study

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Coronary interventions Stents ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Yong Hoon Kim

Kangwon National University College of Medicine, Chuncheon (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
A meta-analysis of randomised controlled trials to compare safety and efficacy of everolimus/sirolimus bioabsorbable polymer with second-generation durable-polymer drug eluting stents
Associate Professor K. Singh (Gold Coast, AU)
Abstract Slides
Presentation thumbnail
First-in-man study of the dedicated bifurcation cobalt-chromium sirolimus-eluting stent: 9-month interim results.
Professor R. Gil (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Unique stent design with continuous cobalt wire can avoid protruding immediately after percutaneous coronary intervention compared to classical tubed stent.
Doctor D. Nakamura (Osaka, JP)
Abstract
Presentation thumbnail
Clinical impact of implanted stent length on clinical outcomes in patients treated with second-generation DES: a pooled analysis from RESET and NEXT trial
Mr H. Watanabe (Wakayama, JP)
Abstract
Presentation thumbnail
A five-year follow-up of randomised studies comparing outcomes between bioabsorbable-polymer and durable-polymer drug-eluting stents: systematic review and meta-analysis
Associate Professor K. Singh (Gold Coast, AU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Coronary interventions

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Session
Complex PCI in practice: tips and tricks to take home
thumbnail
Congress Session
PCI complications: the lyrics from my worst nightmares

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources